Evidence map›Paper›PMID 39283667›Full record

Trial reportJMIR public health and surveillance2024

e-Cigarettes, Smoking Cessation, and Weight Change: Retrospective Secondary Analysis of the Evaluating the Efficacy of e-Cigarette Use for Smoking Cessation Trial.

Lynnette Lyzwinski, Meichen Dong, Russell D Wolfinger, Kristian B Filion, Mark J Eisenberg

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JMIR public health and surveillance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02417467 (Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02417467 phase3completednot on this map

Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation (E3) Trial

TypeinterventionalSponsorMcGill UniversityRan2016 to 2020Enrolled376ConditionsSmoking CessationArmsNicotine E-Cigarette, Non-Nicotine E-Cigarette, Counseling
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lynnette Lyzwinski *Centre for Clinical Epidemiology, Lady Davis Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0002-6173-4505
Meichen Dong *JMP Statistical Discovery LLC, Cary, NC, United States.ORCID 0000-0001-9437-9290
Russell D WolfingerJMP Statistical Discovery LLC, Cary, NC, United States.ORCID 0000-0001-8575-0537
Kristian B FilionCentre for Clinical Epidemiology, Lady Davis Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0001-6055-0088
Mark J EisenbergCentre for Clinical Epidemiology, Lady Davis Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0002-1296-0661

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile smoking cessation has been linked to substantial weight gain, the potential influence of e-cigarettes on weight changes among individuals who use these devices to quit smoking is not fully understood.

objectiveThis study aims to reanalyze data from the Evaluating the Efficacy of e-Cigarette Use for Smoking Cessation (E3) trial to assess the causal effects of e-cigarette use on change in body weight.

methodsThis is a secondary analysis of the E3 trial in which participants were randomized into 3 groups: nicotine e-cigarettes plus counseling, nonnicotine e-cigarettes plus counseling, and counseling alone. With adjustment for baseline variables and the follow-up smoking abstinence status, weight changes were compared between the groups from baseline to 12 weeks' follow-up. Intention-to-treat and as-treated analyses were conducted using doubly robust estimation. Further causal analysis used 2 different propensity scoring methods to estimate causal regression curves for 4 smoking-related continuous variables. We evaluated 5 different subsets of data for each method. Selection bias was addressed, and missing data were imputed by the machine learning method extreme gradient boosting (XGBoost).

resultsA total of 257 individuals with measured weight at week 12 (mean age: 52, SD 12 y; women: n=122, 47.5%) were included. Across the 3 treatment groups, of the 257 participants, 204 (79.4%) who continued to smoke had, on average, largely unchanged weight at 12 weeks, with comparable mean weight gain ranging from -0.24 kg to 0.33 kg, while 53 (20.6%) smoking-abstinent participants gained weight, with a mean weight gain ranging from 2.05 kg to 2.70 kg. After adjustment, our analyses showed that the 2 e-cigarette arms exhibited a mean gain of 0.56 kg versus the counseling alone arm. The causal regression curves analysis also showed no strong evidence supporting a causal relationship between weight gain and the 3 e-cigarette-related variables. e-Cigarettes have small and variable causal effects on weight gain associated with smoking cessation.

conclusionsIn the E3 trial, e-cigarettes seemed to have minimal effects on mitigating the weight gain observed in individuals who smoke and subsequently quit at 3 months. However, given the modest sample size and the potential underuse of e-cigarettes among those randomized to the e-cigarette treatment arms, these results need to be replicated in large, adequately powered trials.

trial registrationClinicalTrials.gov NCT02417467; https://www.clinicaltrials.gov/study/NCT02417467.

Indexed as

Electronic Nicotine Delivery SystemsSmoking CessationAdultBody WeightFemaleHumansMaleMiddle AgedRetrospective StudiesWeight Gaine-cigarettesnicotinesmoking cessationvapingweight changeweight gain

Identifiers

PMID39283667
PMCPMC11443201

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.